Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Tétreault

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Journal of Medicinal Chemistry|September 9, 2015
Synthesis and Characterization in Vitro and in Vivo of (l)-(Trimethylsilyl)alanine Containing Neurotensin AnaloguesRoberto Fanelli, Élie Besserer-Offroy, Adeline René, et al.
Molecular Pain|June 17, 2016
Functional inhibition of chemokine receptor CCR2 by dicer-substrate-siRNA prevents pain developmentValérie Bégin-Lavallée, Élora Midavaine, Marc-André Dansereau, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 13, 2013
Spinal NTS2 receptor activation reverses signs of neuropathic painPascal Tétreault, Nicolas Beaudet, Amélie Perron, et al.
Data in Brief|July 9, 2020
Data set describing the <i>in vitro</i> biological activity of JMV2009, a novel silylated neurotensin(8-13) analogÉlie Besserer-Offroy, Pascal Tétreault, Rebecca L Brouillette, et al.
European Journal of Pharmacology|June 14, 2020
Pain relief devoid of opioid side effects following central action of a silylated neurotensin analogPascal Tétreault, Élie Besserer-Offroy, Rebecca L Brouillette, et al.
Pain and Therapy|August 10, 2021
Sex-Specific Pharmacotherapy for Back Pain: A Proof-of-Concept Randomized TrialDiane Reckziegel, Pascal Tétreault, Mariam Ghantous, et al.
Brain : a Journal of Neurology|May 19, 2016
Corticolimbic anatomical characteristics predetermine risk for chronic painEtienne Vachon-Presseau, Pascal Tétreault, Bogdan Petre, et al.
Pain|July 15, 2025
Impact of different acute low back pain definitions on the predictors and on the risk of transition to chronic low back pain: a prospective longitudinal cohort studyRachael O Osagie, Iulia Tufa, Adriana Angarita-Fonseca, et al.
The Journal of Clinical Investigation|February 18, 2014
Conjugation of a brain-penetrant peptide with neurotensin provides antinociceptive propertiesMichel Demeule, Nicolas Beaudet, Anthony Régina, et al.
Pain|January 13, 2023
The Canadian version of the National Institutes of Health minimum dataset for chronic low back pain research: reference values from the Quebec Low Back Pain StudyAdriana Angarita-Fonseca, M Gabrielle Pagé, Carolina B Meloto, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Medicinal Chemistry|September 9, 2015
Synthesis and Characterization in Vitro and in Vivo of (l)-(Trimethylsilyl)alanine Containing Neurotensin AnaloguesRoberto Fanelli, Élie Besserer-Offroy, Adeline René, et al.
Molecular Pain|June 17, 2016
Functional inhibition of chemokine receptor CCR2 by dicer-substrate-siRNA prevents pain developmentValérie Bégin-Lavallée, Élora Midavaine, Marc-André Dansereau, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 13, 2013
Spinal NTS2 receptor activation reverses signs of neuropathic painPascal Tétreault, Nicolas Beaudet, Amélie Perron, et al.
Data in Brief|July 9, 2020
Data set describing the <i>in vitro</i> biological activity of JMV2009, a novel silylated neurotensin(8-13) analogÉlie Besserer-Offroy, Pascal Tétreault, Rebecca L Brouillette, et al.
European Journal of Pharmacology|June 14, 2020
Pain relief devoid of opioid side effects following central action of a silylated neurotensin analogPascal Tétreault, Élie Besserer-Offroy, Rebecca L Brouillette, et al.
Pain and Therapy|August 10, 2021
Sex-Specific Pharmacotherapy for Back Pain: A Proof-of-Concept Randomized TrialDiane Reckziegel, Pascal Tétreault, Mariam Ghantous, et al.
Brain : a Journal of Neurology|May 19, 2016
Corticolimbic anatomical characteristics predetermine risk for chronic painEtienne Vachon-Presseau, Pascal Tétreault, Bogdan Petre, et al.
Pain|July 15, 2025
Impact of different acute low back pain definitions on the predictors and on the risk of transition to chronic low back pain: a prospective longitudinal cohort studyRachael O Osagie, Iulia Tufa, Adriana Angarita-Fonseca, et al.
The Journal of Clinical Investigation|February 18, 2014
Conjugation of a brain-penetrant peptide with neurotensin provides antinociceptive propertiesMichel Demeule, Nicolas Beaudet, Anthony Régina, et al.
Pain|January 13, 2023
The Canadian version of the National Institutes of Health minimum dataset for chronic low back pain research: reference values from the Quebec Low Back Pain StudyAdriana Angarita-Fonseca, M Gabrielle Pagé, Carolina B Meloto, et al.
Pageof 3